USPTO Patent Grant: Immunopotentiating Amino Acid Mineral Complex
Summary
The USPTO has granted a patent (US12583873B2) to BTN CO., LTD. for an amino acid mineral complex with immunopotentiating activity. This complex can be used in compositions for foods, pharmaceuticals, or feeds to enhance immunity or antibody production in humans and animals.
What changed
The United States Patent and Trademark Office (USPTO) has issued patent US12583873B2 for an "Amino acid mineral complex having immunopotentiating activity and composition for foods, pharmaceuticals, or feeds comprising same." The patent, assigned to BTN CO., LTD., covers a composition that includes an amino acid mineral complex as an active ingredient, intended to enhance immunity or increase antibody production rates in humans and animals. The filing date for this application was November 26, 2018.
This patent grant is primarily informational and does not impose new regulatory obligations on regulated entities. However, companies involved in the development or manufacturing of pharmaceuticals, food additives, or animal feed supplements may find this patent relevant for intellectual property considerations or as a basis for developing new products. No immediate compliance actions are required for entities not directly involved in the patent's scope.
Archived snapshot
Mar 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Amino acid mineral complex having immunopotentiating activity and composition for foods, pharmaceuticals, or feeds comprising same
Grant US12583873B2 Kind: B2 Mar 24, 2026
Assignee
BTN CO., LTD.
Inventors
Byoung Ryol Lee
Abstract
The present invention relates to an amino acid mineral complex having immunopotentiating activity, and a composition for foods, pharmaceuticals, or feeds comprising the same. More particularly, the present invention relates to a composition for foods (or a food additive), pharmaceuticals, or feeds (or a feed additive) which comprises the amino acid mineral complex as an active ingredient so that it is possible to enhance the immunity of a human or an animal other than a human or increase the antibody production rate of an anti-virus vaccine.
CPC Classifications
C07F 3/06 A23K 20/142 A23K 20/24 A23K 50/30 A23L 33/175 A23L 33/29 A23L 33/165 A61K 31/198 A61K 33/30 A61K 39/12 Y02A 50/30 A61P 31/14 A61P 31/16 A61P 37/04
Filing Date
2018-11-26
Application No.
17262149
Claims
6
Named provisions
Related changes
Get daily alerts for ChangeBridge: Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Grants - Therapeutics (A61P) publishes new changes.